Ultragenyx Pharmaceutical, Inc.

33
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90400D1081
USD
36.54
3.07 (9.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
560.00
434.00
363.00
351.00
271.00
103.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
560.00
434.00
363.00
351.00
271.00
103.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
63.00
66.00
43.00
29.00
33.00
1.00
General and Administration Expenses
321.00
309.00
278.00
219.00
170.00
152.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,096.00
1,003.00
1,012.00
733.00
587.00
527.00
Operating Profit (PBDIT) excl Other Income
-535.00
-569.00
-648.00
-381.00
-316.00
-424.00
Other Income
32.00
26.00
9.00
0.00
7.00
12.00
Operating Profit (PBDIT)
-467.00
-516.00
-621.00
-368.00
-297.00
-403.00
Interest
63.00
66.00
43.00
29.00
33.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
35.00
26.00
18.00
13.00
12.00
8.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-567.00
-608.00
-701.00
-452.00
-185.00
-399.00
Provision for Tax
1.00
-1.00
5.00
1.00
1.00
3.00
Profit After Tax
-569.00
-606.00
-707.00
-454.00
-186.00
-402.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-6.29
-8.25
-10.12
-6.70
-3.07
-7.12
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 29.01% vs 19.52% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 5.84% vs 12.28% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -4.49% vs 53.44% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 6.17% vs 14.25% in Dec 2023

Compare Profit and Loss Results of Ultragenyx Pharmaceutical, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
560.00
0.00
560.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
560.00
0.00
560.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
63.00
4.00
59.00
1,475.00%
General and Administration Expenses
321.00
37.00
284.00
767.57%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,096.00
285.00
811.00
284.56%
Operating Profit (PBDIT) excl Other Income
-535.00
-285.00
-250.00
-87.72%
Other Income
32.00
38.00
-6.00
-15.79%
Operating Profit (PBDIT)
-467.00
-247.00
-220.00
-89.07%
Interest
63.00
4.00
59.00
1,475.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
35.00
0.00
35.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-567.00
-252.00
-315.00
-125.00%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
-569.00
-252.00
-317.00
-125.79%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-6.2867
-3.7544
-2.53
-67.45%
Profit And Loss - Net Sales
Net Sales 560.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 29.01% vs 19.52% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -535.97 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 5.84% vs 12.28% in Dec 2023

Profit And Loss - Interest
Interest 63.04 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -4.49% vs 53.44% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax -569.18 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.17% vs 14.25% in Dec 2023